Andrew Hessel: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
I consult in synthetic biology technology and education, open source biology, the international Genetically Engineered Machines (iGEM) program | I consult in synthetic biology technology and education, open source biology, the international Genetically Engineered Machines (iGEM) program, DIYbio, and open innovation models with a focus on Canada. I am also involved with the [http://singularityu.org Singularity University]. | ||
My goal is to help grow a next-generation biotechnology industry that can better address environmental, health, and manufacturing concerns. I do this by raising awareness of the tools and technologies | My goal is to help grow a next-generation biotechnology industry that can better address environmental, health, and manufacturing concerns. I do this by raising awareness of the emerging tools and technologies with students, scientists, government officials, and business leaders; by facilitating introductions; and by helping groups or regions find the economic and other resources necessary to participate. My current focus is preparing for launch a new Canada-based cooperative biotechnology company focused on breast cancer therapeutics. | ||
Please eontact me if you are interested in learning the landscape of synthetic biology, creating iGEM or undergraduate programs in your area, or considering investments in for-profit, non-profit, or open source biotechnology. | |||
Revision as of 10:22, 2 April 2009
I consult in synthetic biology technology and education, open source biology, the international Genetically Engineered Machines (iGEM) program, DIYbio, and open innovation models with a focus on Canada. I am also involved with the Singularity University.
My goal is to help grow a next-generation biotechnology industry that can better address environmental, health, and manufacturing concerns. I do this by raising awareness of the emerging tools and technologies with students, scientists, government officials, and business leaders; by facilitating introductions; and by helping groups or regions find the economic and other resources necessary to participate. My current focus is preparing for launch a new Canada-based cooperative biotechnology company focused on breast cancer therapeutics.
Please eontact me if you are interested in learning the landscape of synthetic biology, creating iGEM or undergraduate programs in your area, or considering investments in for-profit, non-profit, or open source biotechnology.
Contact Information
LinkedIn profile
hi-res photo
email: ahessel (at) gmail (dot) com
phone: 780.868.3169
Skype: search for "Andrew Hessel", ahessel (at) gmail (dot) com
2008 Talks, Conferences, Posters
Convergence 08, Panel Debate, Talk, November 15-16, 2008
iGEM Jamboree, MIT, Cambridge, MA, November 7-9, 2008 (Chairing iGEM Canada session)
Singularity Summit 2008, San Jose, CA, October 25, 2008 (attending)
UofC Engineering, Calgary, Sept 24, 2008 (Engineering Biology)
SciFoo, Mountain View, CA, August 8-10, 2008
BioBarCamp, Palo Alto, CA, August 6-7, 2008
Science Cafe, Telus World of Science and Alberta Ingenuity, Edmonton, May 6, 2008
Sanofi Aventis BioTalent Challenge Keynote, Calgary, April 23, 2008
Sanofi Aventis BioTalent Challenge Keynote, Edmonton, April 16, 2008
Civil Society Synthetic Biology Teach-In, Washington DC, April 14, 2008 PDF
TEC Edmonton, Open Source Therapeutics, round 2, March 31, 2008
TEC Edmonton, Open Source Therapeutics, March 19, 2008
Overview of iGEM program, Edmonton Catholic School Board, March 18, 2008
Open Source Therapeutics. UofA Digital Biology Meeting, March 17, 2008
National Post Article on SciBarCamp by David Sachs.
Synbio Debate w/ Jim Thomas, ETC group; open source therapeutics scibarcamp, Toronto, May 14-16, 2008
Southern Alberta Institute of Technology (SAIT), Overview of Synthetic Biology, February 2008.
2007 Talks and Posters
iGEM and Synthetic Biology: Opportunities for Canada, University of Ottawa, November 23, 2007 audio by request
SemBioSys Biotechnologies, Calgary, Alberta, October 26, 2007
Synthetic Biology, Risks, Rewards, and Opportunities, Cross Cancer Institute, Edmonton, October 23 audio by request
Synthetic Viruses Targeting Cancer, SENS 3, Cambridge UK, September 7Video
Overview of synthetic biology, University of Lethbridge, July 19
University of Alberta Department Chairs and Divisional Directors Meeting, July 4
SB3.0 Poster -- iGEM: A case study for open source biological engineering
MIT TTT Canada overview May 26 Video